TSE:L

Loblaw Companies Ltd (L.TO)

66.47
+1.70 (2.62%)
as of Jun 24, 2026, 5:09:45 pm Market Open.
323 watching
0
Investor Insights
star iconJun 24, 2026, 12:00 am

This summary was created by AI, based on 15 opinions in the last 12 months.

Loblaw Companies Ltd. is Canada's leading food and drug retailer, effectively navigating challenges posed by inflation and competition. Analysts commend its strategic focus on discount formats like No Frills and the strong performance of its private labels, particularly the No Name brand. The acquisition of Shoppers Drug Mart has proven beneficial, generating robust free cash flow, and establishing a solid market position with organic growth prospects. While some experts express concerns about its current valuation being high, the company remains a reliable defensive choice in uncertain economic times. Overall, experts acknowledge its significant market share, operational efficiencies, and impressive revenue growth despite mixed sentiment regarding its valuation relative to competitors.

consensus icon
Consensus
Positive
valuation icon
Valuation
Overvalued
review icon
Similar
CST, CST
DON'T BUY
Stellar performance/management, but investors who used it as a defense stock may pull out now.
TOP PICK
Stable growth rate. Good management.
BUY
A premier company.
TOP PICK
Good business model. Defensive stock.
BUY
Not cheap, but has good defensive qualities.
BUY
Defensive stock. Good company.
DON'T BUY
Too expensive.
BUY
Weathers recessions quite well. Good mngmnt. Long term growth.
BUY
A defensive stock. Good upside potential.
DON'T BUY
Expensive at 26 X earnings. Will have slow growth.
BUY
Solid company. Good cash flow. Strong management.
STRONG BUY
Likes under $50. Good price now.
WAIT
Stock has dropped on news that Weston's was selling some stock. Could have a further drop.
TOP PICK
Good defensive stock.
DON'T BUY
Prefers owning George Weston as a way of owning Loblaws.
Showing 661 to 675 of 706 entries